RA studies lag in examining comorbid populations - Healio
December 30, 2022 3 min read Source/Disclosures Published by: Source: Healio Interview Disclosures: England reports consulting for, and receiving research funding from, Boehringer-Ingelheim. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . " data-action="subscribe"> Subscribe ADDED TO EMAIL ALERTS We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio A slew of recent clinical trials and the continued development of new treatments have ensured that the state of rheumatoid arthritis treatment is more advanced than ever before. But patients with RA are notoriously at a very high risk of developing comorbi...